We hypothesize that hyperglycaemia could differentially repress NKX2.5–LIPTER expression levels in individual CMs, and CMs with critically low LIPTER expression levels could gradually die, with this slow progress of muscle loss eventually leading to DCM of diabetic hearts. The gene discussed is NKX2-5; the disease is Hyperglycemia.